{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T21:35:00Z","timestamp":1789594500002,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T00:00:00Z","timestamp":1659571200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T00:00:00Z","timestamp":1659571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Haemostatic derangements are thought to be due to an imbalance between hepatic synthesis of pro-coagulants and urinary losses of anticoagulants.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Objectives<\/jats:title>\n                <jats:p>This study evaluated the coagulation profile of Nigerian children with nephrotic syndrome and examined the relationship between coagulation variables, disease state and steroid responsiveness.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A cross- sectional hospital based study on evaluation of coagulation profile of children with nephrotic syndrome compared with their age- and gender- matched controls.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The median fibrinogen level in subjects and controls was the same (2.9\u00a0g\/L). Sixteen of 46 (35%) children with nephrotic syndrome had hyperfibrinogenaemia. The median fibrinogen level of children in remission was 2.3\u00a0g\/L and differed significantly when compared with those of children in relapse (<jats:italic>p<\/jats:italic>\u2009=\u2009<jats:italic>0.001<\/jats:italic>). The median APTT of children with nephrotic syndrome was 45.0\u00a0s and differed significantly compared with those of controls (42.0\u00a0s) <jats:italic>(p value<\/jats:italic>\u2009=\u2009<jats:italic>0.02<\/jats:italic>). The median prothrombin time in children with and without nephrotic syndrome were 12.0 and 13.0\u00a0s respectively<jats:italic>, (p<\/jats:italic>\u2009=\u2009<jats:italic>0.004).<\/jats:italic> About 90% of children with nephrotic syndrome had INR within reference range. Thrombocytosis was found in 15% of children with nephrotic syndrome. The median platelet count in children with new disease was 432\u2009\u00d7\u200910<jats:sup>3<\/jats:sup>cells\/mm<jats:sup>3<\/jats:sup> and differed significantly when compared with those of controls <jats:italic>(p<\/jats:italic>\u2009=\u2009<jats:italic>0.01<\/jats:italic>).<\/jats:p>\n                <jats:p>INR was significantly shorter in children with steroid resistant nephrotic syndrome (SRNS) (median 0.8\u00a0s; IQR 0.8 -0.9\u00a0s) compared with controls (median 1.0\u00a0s; IQR 1.0 -1.1\u00a0s) <jats:italic>(p<\/jats:italic>\u2009=\u2009<jats:italic>0.01)<\/jats:italic>. Steroid sensitivity was the strongest predictor of remission in children with nephrotic syndrome; steroid sensitive patients were 30 times more likely to be in remission than in relapse (OR 30.03; CI 2.01 \u2013 448.04).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This study shows that the haemostatic derangements in childhood nephrotic involve mostly fibrinogen, APTT, PT, INR and platelet counts. Antithrombin levels are largely unaffected. Variations in fibrinogen, APTT, PT and INR values may be due to the heterogeneous nature of the disease.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12882-022-02894-5","type":"journal-article","created":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T10:03:03Z","timestamp":1659607383000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Haemostatic profile of children with nephrotic syndrome attending University of Nigeria Teaching Hospital Ituku-Ozalla, Nigeria"],"prefix":"10.1186","volume":"23","author":[{"given":"Chioma L.","family":"Odimegwu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony N.","family":"Ikefuna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrietta U.","family":"Okafor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Nwagha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agozie","family":"Ubesie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephat M.","family":"Chinawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,4]]},"reference":[{"key":"2894_CR1","unstructured":"Pais P, Avner ED. Nephrotic syndrome. In: Kliegman RM, Stanton BF, III JWSG, Shor NF, editors. Nelson textbook of pediatrics. 19th ed. Philadelphia: Elsevier; 2011. p. 6483\u20138."},{"key":"2894_CR2","doi-asserted-by":"crossref","unstructured":"Ress L, Brogan P, Bockenhauer D, Webb N. Glomerular disease. In: Ress L, Brogan P, Bockenhauer D, Webb N, editors. Paediatric Nephrology, vol. 9. 2nd ed. Oxford: Oxford University Press; 2012. p. 192.","DOI":"10.1093\/med\/9780199601370.001.0001"},{"key":"2894_CR3","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s00467-004-1620-z","volume":"20","author":"AM Wasilewska","year":"2005","unstructured":"Wasilewska AM, Zoch-Zwierz WM, Tomaszewska B, Biernacka A. Platelet-derived growth factor and platelet profiles in childhood nephrotic syndrome. Pediatr Nephrol. 2005;20:36\u201341.","journal-title":"Pediatr Nephrol"},{"key":"2894_CR4","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1056\/NEJM199804233381707","volume":"338","author":"SR Orth","year":"1998","unstructured":"Orth SR, Ritz E. The nephrotic syndrome. N Engl J Med. 1998;338:1202\u201311.","journal-title":"N Engl J Med"},{"key":"2894_CR5","first-page":"17","volume":"72","author":"S Kirdpon","year":"1989","unstructured":"Kirdpon S, Vuttivirojana A, Kovitangkoon K, Poolsawat SS. The primary nephrotic syndrome in children and histopathologic study. J Med Assoc Thai. 1989;72:17\u201321.","journal-title":"J Med Assoc Thai"},{"key":"2894_CR6","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s004679900253","volume":"15","author":"MI Lilova","year":"2000","unstructured":"Lilova MI, Velkovski IG, Topalov IB. Thromboembolic complications in children with nephrotic syndrome in Bulgaria (1974\u20131996). Pediatr Nephrol. 2000;15:74\u20138.","journal-title":"Pediatr Nephrol"},{"key":"2894_CR7","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/s004670050029","volume":"14","author":"AG Citak","year":"2000","unstructured":"Citak AG, Emre S, Sairin A, Bilge I, Nay\u0131r A. Hemostatic problems and thromboembolic complications in nephrotic children. Pediatr Nephrol. 2000;14:138\u201342.","journal-title":"Pediatr Nephrol"},{"key":"2894_CR8","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1182\/blood.V83.5.1251.1251","volume":"83","author":"M Andrew","year":"1994","unstructured":"Andrew M, David M, Adams M, Ali K, Anderson R, Barnard D, et al. Venous thromboembolic complications (VTE) in children: first analyses of the Canadian registry of VTE. Blood. 1994;83:1251\u20137.","journal-title":"Blood"},{"key":"2894_CR9","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jpeds.2009.01.070","volume":"155","author":"BA Kerlin","year":"2009","unstructured":"Kerlin BA, Blatt NB, Fuh B, Zhao S, Lehman A, Blanchong C, et al. Epidemiology and risk factors for thromboembolic complications of childhood nephrotic syndrome: a Midwest Paediatric Nephrology Consortium (MWPNC) study. J Pediatr. 2009;155:105\u201310.","journal-title":"J Pediatr"},{"key":"2894_CR10","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(03)14184-0","volume":"362","author":"AA Eddy","year":"2003","unstructured":"Eddy AA, Symons JM. Nephrotic syndrome in childhood. The Lancet. 2003;362:629\u201339.","journal-title":"The Lancet"},{"key":"2894_CR11","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1148\/radiol.14140121","volume":"273","author":"LJ Zhang","year":"2014","unstructured":"Zhang LJ, Zhang Z, Li SJ, Meinel FG, Nance JW Jr, Zhou CS, et al. Pulmonary embolism and renal vein thrombosis in patients with nephrotic syndrome: prospective evaluation of prevalence and risk factors with CT. Radiology. 2014;273:897\u2013906.","journal-title":"Radiology"},{"key":"2894_CR12","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.jvs.2007.11.054","volume":"47","author":"JA Sandoval","year":"2008","unstructured":"Sandoval JA, Sheehan MP, Stonerock CE, Shafique S, Rescorla FJ, Dalsing MC. Incidence, risk factors, and treatment patterns for deep venous thrombosis in hospitalized children: an increasing population at risk. J Vasc Surg. 2008;47:837\u201343.","journal-title":"J Vasc Surg"},{"key":"2894_CR13","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s10157-013-0917-2","volume":"18","author":"D Suri","year":"2014","unstructured":"Suri D, Ahluwalia J, Saxena AK, Sodhi KS, Singh P, Mittal BR, et al. Thromboembolic complications in childhood nephrotic syndrome: a clinical profile. Clin Exp Nephrol. 2014;18:803\u201313.","journal-title":"Clin Exp Nephrol"},{"key":"2894_CR14","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1159\/000188604","volume":"70","author":"A Sagripanti","year":"1995","unstructured":"Sagripanti A, Barsotti G. Hypercoagulability, intraglomerular coagulation and thromboembolism in nephrotic syndrome. Nephron. 1995;70:271\u201381.","journal-title":"Nephron"},{"key":"2894_CR15","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/ki.1985.149","volume":"28","author":"F Llach","year":"1985","unstructured":"Llach F. Hypercoagulability, renal vein thrombosis, and other thrombotic complications of nephrotic syndrome. Kidney Int. 1985;28:429\u201339.","journal-title":"Kidney Int"},{"key":"2894_CR16","doi-asserted-by":"publisher","first-page":"121","DOI":"10.4103\/0253-7176.116232","volume":"35","author":"J Charan","year":"2013","unstructured":"Charan J, Biswas T. How to calculate sample size for different study designs in medical research? Indian J Psychol Med. 2013;35:121\u20136.","journal-title":"Indian J Psychol Med"},{"key":"2894_CR17","doi-asserted-by":"crossref","unstructured":"Pequegnat W,\u00a0 Stover E, Ellen B, Cheryl A. How to Write a Successful Research Grant Application: A Guide for Social and Behavioral Scientists . Springer. 2010. p. 1\u2013420.","DOI":"10.1007\/978-1-4419-1454-5"},{"key":"2894_CR18","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1136\/bmj.332.7547.969","volume":"332","author":"JC Dumville","year":"2006","unstructured":"Dumville JC, Torgerson DJ, Hewitt CE. Reporting attrition in randomised control trials. BMJ. 2006;332:969\u201371.","journal-title":"BMJ"},{"key":"2894_CR19","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1007\/BF01955944","volume":"150","author":"AT Elidrissy","year":"1991","unstructured":"Elidrissy AT, Abdurrahman MB, Bahakim HM, Jones MD, Gader AM. Haemostatic measurements in childhood nephrotic syndrome. Eur J Pediatr. 1991;150:374\u20138.","journal-title":"Eur J Pediatr"},{"key":"2894_CR20","first-page":"304","volume":"26","author":"MM Al-Mugeiren","year":"1996","unstructured":"Al-Mugeiren MM, Gader AM, Al-Rasheed SA, Bahakim HM, Al-Momen AK, Al-Salloum A. Coagulopathy of childhood nephrotic syndrome\u2013a reappraisal of the role of natural anticoagulants and fibrinolysis. Haemostasis. 1996;26:304\u201310.","journal-title":"Haemostasis"},{"key":"2894_CR21","doi-asserted-by":"publisher","first-page":"89","DOI":"10.5455\/2349-3291.ijcp20140805","volume":"1","author":"AS Rani","year":"2014","unstructured":"Rani AS. A study of PT, APTT, fibrinogen and urinary protein-creatinine ratio in paediatric patients with nephrotic syndrome. Int J Contemp Pediatr. 2014;1:89\u201393.","journal-title":"Int J Contemp Pediatr"},{"key":"2894_CR22","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s12882-015-0208-0","volume":"16","author":"AO Asinobi","year":"2015","unstructured":"Asinobi AO, Ademola AD, Okolo CA, Yaria JO. Trends in the histopathology of childhood nephrotic syndrome in Ibadan Nigeria: preponderance of idiopathic focal segmental glomerulosclerosis. BMC Nephrol. 2015;16:213.","journal-title":"BMC Nephrol"},{"key":"2894_CR23","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1007\/s00467-016-3509-z","volume":"31","author":"C Dossier","year":"2016","unstructured":"Dossier C, Lapidus N, Bayer F, Sellier-Leclerc AL, Boyer O, de Pontual L, et al. Epidemiology of idiopathic nephrotic syndrome in children: endemic or epidemic? Pediatr Nephrol. 2016;31:2299\u2013308.","journal-title":"Pediatr Nephrol"},{"key":"2894_CR24","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/j.1440-1754.2007.01077.x","volume":"43","author":"W Wong","year":"2007","unstructured":"Wong W. Idiopathic nephrotic syndrome in New Zealand children, demographic, clinical features, initial management and outcome after twelve-month follow-up: results of a three-year national surveillance study. J Paediatr Child Health. 2007;43:337\u201341.","journal-title":"J Paediatr Child Health"},{"key":"2894_CR25","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1007\/s00467-011-1851-8","volume":"26","author":"L El Bakkali","year":"2011","unstructured":"El Bakkali L, Rodrigues Pereira R, Kuik DJ, Ket JC, van Wijk JA. Nephrotic syndrome in The Netherlands: a population-based cohort study and a review of the literature. Pediatr Nephrol. 2011;26:1241\u20136.","journal-title":"Pediatr Nephrol"},{"key":"2894_CR26","doi-asserted-by":"publisher","first-page":"732","DOI":"10.5301\/jn.5000051","volume":"25","author":"A Kaddah","year":"2012","unstructured":"Kaddah A, Sabry S, Emil E, El-Refaey M. Epidemiology of primary nephrotic syndrome in Egyptian children. J Nephrol. 2012;25:732\u20137.","journal-title":"J Nephrol"},{"key":"2894_CR27","first-page":"14","volume":"26","author":"BA Okoro","year":"1999","unstructured":"Okoro BA, Okafor HU. Pattern of Childhood Renal Disorders in Enugu. Niger J Paediatr. 1999;26:14\u20138.","journal-title":"Niger J Paediatr"},{"key":"2894_CR28","first-page":"256","volume":"4","author":"IS Etuk","year":"2006","unstructured":"Etuk IS, Anah MU, Ochighs SO, Eyong M. Pattern of paediatric renal disease in inpatients in Calabar. Nigeria Sage J. 2006;4:256\u2013256.","journal-title":"Nigeria Sage J"},{"key":"2894_CR29","doi-asserted-by":"crossref","unstructured":"Mittal A, Aggarwal KC, Saluja S, Aggarwal A, Sureka B. Platelet functions and coagulation changes in Indian children with nephrotic syndrome. J Clin Diagn Res. 2013 ;7(8):1647\u201350.","DOI":"10.7860\/JCDR\/2013\/5488.3229"},{"key":"2894_CR30","first-page":"1005","volume":"33","author":"NK Anand","year":"1996","unstructured":"Anand NK, Chand G, Talib VH, Chellani H, Pande J. Hemostatic profile in nephrotic syndrome. Indian Pediatr. 1996;33:1005\u201312.","journal-title":"Indian Pediatr"},{"key":"2894_CR31","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1007\/s00467-013-2525-5","volume":"29","author":"BA Kerlin","year":"2014","unstructured":"Kerlin BA, Haworth K, Smoyer WE. Venous thromboembolism in pediatric nephrotic syndrome. Pediatr Nephrol. 2014;29:989\u201397.","journal-title":"Pediatr Nephrol"},{"key":"2894_CR32","first-page":"377","volume":"5","author":"G Wygledowska","year":"2001","unstructured":"Wygledowska G, Grygalewicz J, Matuszewska E. Natural coagulation inhibitors; antithrombin III, protein C, protein S in children with hypercoagulation due to nephrotic syndrome. Med Wieku Rozwoj. 2001;5:377\u201388.","journal-title":"Med Wieku Rozwoj"},{"key":"2894_CR33","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.1681\/ASN.2014111097","volume":"26","author":"BA Kerlin","year":"2015","unstructured":"Kerlin BA, Waller AP, Sharma R, Chanley MA, Nieman MT, Smoyer WE. Disease severity correlates with thrombotic capacity in experimental nephrotic syndrome. J Am Soc Nephrol. 2015;26:3009\u201319.","journal-title":"J Am Soc Nephrol"},{"key":"2894_CR34","doi-asserted-by":"publisher","first-page":"187","DOI":"10.5144\/0256-4947.1990.187","volume":"10","author":"RR Duarte","year":"1990","unstructured":"Duarte RR, Mughal TI, Al-Rogi A. Blood Coagulation and the Nephrotic Syndrome: Deficiency or Excess? Ann Saudi Med. 1990;10:187\u201393.","journal-title":"Ann Saudi Med"},{"key":"2894_CR35","doi-asserted-by":"publisher","unstructured":"Mansfield L. The reading, writing, and arithmetic of the medical literature, part 2: critical evaluation of statistical reporting. Ann Allergy Asthma Immunol. 2005;95(4):315\u201321; quiz 322, 380. https:\/\/doi.org\/10.1016\/S1081-1206(10)61148-9.","DOI":"10.1016\/S1081-1206(10)61148-9"},{"key":"2894_CR36","doi-asserted-by":"publisher","unstructured":"Wood J, Freemantle N, King M, Nazareth I. Trap of trends to statistical significance: likelihood of near significant P value becoming more significant with extra data. BMJ. 2014;348:g2215. https:\/\/doi.org\/10.1136\/bmj.g2215.","DOI":"10.1136\/bmj.g2215"},{"key":"2894_CR37","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1093\/bja\/aev149","volume":"115","author":"NM Gibbs","year":"2015","unstructured":"Gibbs NM, Gibbs SV. Misuse of \u2018trend\u2019 to describe \u2018almost significant\u2019 differences in anaesthesia research. BJA. 2015;115:337\u20139.","journal-title":"BJA"},{"key":"2894_CR38","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1053\/ajkd.2003.50116","volume":"41","author":"F Fakhouri","year":"2003","unstructured":"Fakhouri F, Bocquet N, Taupin P, Presne C, Gagnadoux MF, Landais P, et al. Steroid-sensitive nephrotic syndrome: from childhood to adulthood. Am J Kidney Dis. 2003;41:550\u20137.","journal-title":"Am J Kidney Dis"},{"key":"2894_CR39","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1136\/adc.63.5.484","volume":"63","author":"L Rees","year":"1988","unstructured":"Rees L, Greene SA, Adlard P, Jones J, Haycock GB, Rigden SP, et al. Growth and endocrine function in steroid sensitive nephrotic syndrome. Arch Dis Child. 1988;63:484\u201390.","journal-title":"Arch Dis Child"},{"key":"2894_CR40","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1111\/j.1651-2227.1995.tb13787.x","volume":"84","author":"J Ksiek","year":"1995","unstructured":"Ksiek J, Wyszyska T. Short versus long initial prednisone treatment in steroid-sensitive nephrotic syndrome in children. Acta Paediatr. 1995;84:889\u201393.","journal-title":"Acta Paediatr"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-022-02894-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-022-02894-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-022-02894-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T10:05:40Z","timestamp":1659607540000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-022-02894-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,4]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2894"],"URL":"https:\/\/doi.org\/10.1186\/s12882-022-02894-5","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,4]]},"assertion":[{"value":"15 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The approval of the Health Research Ethics Committee of the University of Nigeria Teaching Hospital, Enugu was obtained. Patients and parents or caregivers were duly informed in detail about the purpose of the study, the specimen for the study and its method of collection. A written informed consent was obtained from parents or caregivers of all study participants while an assent was obtained in participants aged 7\u00a0years and older.\u00a0All methods were carried out in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"274"}}